【结 构 式】 |
【药物名称】SNS-032, BMS-387032 【化学名称】N-[5-(5-tert-Butyloxazol-2-ylmethylsulfany)thiazol-2-yl]piperidine-4-carboxamide hemi(L-tartrate) 【CA登记号】345627-92-1, 345627-80-7 (free base), 345627-90-9 (hydrochloride), 345627-91-0 (hydrobromide), 345627-96-5 (sulfate), 345627-98- 【 分 子 式 】C38H54N8O10S4 【 分 子 量 】911.143 |
【开发单位】Sunesis Pharmaceuticals, Inc.; licensed from Bristol- Myers Squibb for worldwide development and commercialization. 【药理作用】Cyclin-Dependent Kinase Inhibitor, Oncolytic |
合成路线1
Treatment of 1-bromo-3,3-dimethyl-2-butanone (I) with hexamethylenetetraamine affords the quaternary salt (II), which is then hydrolyzed to amino ketone (III) under acidic conditions (1-3). Alternatively, reaction of butanone (I) with sodium azide in acetone gives the azido derivative (IV), which is reduced with H2 over Pd/C in methanol to yield 1-amino-3,3-dimethyl-2-butanone (III). Acylation of amine (III) with 2-chloroacetyl chloride by means of triethylamine in dichloromethane yields the chloroacetamide (V), which is cyclized in POCl3 at 105 ºC to provide 5-tert-butyl-2-(chloromethyl)oxazole (VI) (1-4). Condensation of chloride (VI) with thiourea gives the S-alkylated thiouronium salt (VII), which is then submitted to alkaline hydrolysis followed by condensation with 2-amino-5-bromothiazole (VIII) under phase-transfer conditions in the presence of tetrabutylammonium sulfate, leading to thioether (IX) (1-3). Acylation of aminothiazole (IX) with 1-Boc-piperidine-4-carboxylic acid (X) —obtained by reaction of piperidine-4-carboxylic acid (XI) with Boc2O and NaOH in dioxane/acetonitrile— by means of EDAC and DMAP in DMF/dichloromethane yields the carboxamide (XII), which is finally deprotected upon treatment with trifluoroacetic acid (1-3) or by means of HCl in hot dioxane/CHCl (4). Scheme 1.
【1】 Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2394552, EP1240166, JP 2003516987, WO 2001044242. |
【2】 Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2417254, EP 1303513, JP 2004509857, WO 2002010162. |
【3】 Kim, K.S., Kimball, D., Cai, Z.-W. et al. (Bristol-Myers Squibb Co.). Aminothiazole inhibitors of cyclin dependent kinases. US 6262096. |
【4】 Misra, N.R., Xiao, H., Kim, K.S. et al. N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. J Med Chem 2004, 47(7): 1719-28. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30809 | 1-bromo-3,3-dimethyl-2-butanone | 5469-26-1 | C6H11BrO | 详情 | 详情 |
(II) | 65780 | C12H23BrN4O | 详情 | 详情 | ||
(III) | 58415 | 1-amino-3,3-dimethyl-2-butanone | 82962-91-2 | C6H13NO | 详情 | 详情 |
(IV) | 58414 | 1-azido-3,3-dimethyl-2-butanone | 76779-98-1 | C6H11N3O | 详情 | 详情 |
(V) | 58416 | 2-chloro-N-(3,3-dimethyl-2-oxobutyl)acetamide | C8H14ClNO2 | 详情 | 详情 | |
(VI) | 58417 | 5-(tert-butyl)-2-(chloromethyl)-1,3-oxazole | 224441-73-0 | C8H12ClNO | 详情 | 详情 |
(VII) | 58418 | 2-({[amino(imino)methyl]sulfanyl}methyl)-5-(tert-butyl)-1,3-oxazole | 345629-22-3 | C9H15N3OS | 详情 | 详情 |
(VIII) | 65781 | 2-Amino-5-bromothiazole monohydrobromide; 5-Bromothiazol-2-amine monohydrobromide | 61296-22-8 | C3H3BrN2S.HBr | 详情 | 详情 |
(IX) | 58420 | 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-amine; 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-ylamine | 224436-97-9 | C11H15N3OS2 | 详情 | 详情 |
(X) | 17404 | 1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid | 84358-13-4 | C11H19NO4 | 详情 | 详情 |
(XI) | 17402 | 4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid | 498-94-2 | C6H11NO2 | 详情 | 详情 |
(XII) | 65782 | tert-Butyl 4-[[5-[[(5-tert-butyloxazol-2-yl)methyl]thio]thiazol-2-yl]carbamoyl]piperidine-1-carboxylate | 345629-23-4 | C22H32N4O4S2 | 详情 | 详情 |
合成路线2
Alternatively, oxazole (VI) can be condensed with 2-amino-5-sulfanylthiazole (XIII) in refluxing ethanol to give thioether (IX). The intermediate 2-amino-5-sulfanylthiazole (XIII) can be obtained by reaction of 2-aminothiazole (XIV) with Br2 and KSCN to give the thiocyanato derivative (XV), which is finally reduced with NaBH4 in ethanol (4). Scheme 2.
【4】 Misra, N.R., Xiao, H., Kim, K.S. et al. N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. J Med Chem 2004, 47(7): 1719-28. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VI) | 58417 | 5-(tert-butyl)-2-(chloromethyl)-1,3-oxazole | 224441-73-0 | C8H12ClNO | 详情 | 详情 |
(IX) | 58420 | 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-amine; 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-ylamine | 224436-97-9 | C11H15N3OS2 | 详情 | 详情 |
(XIII) | 65783 | 2-Amino-5-thiazolethiol | 69950-00-1 | C3H4N2S2 | 详情 | 详情 |
(XIV) | 19795 | 2-Thiazolamine; 1,3-thiazol-2-amine; 1,3-thiazol-2-ylamine | 96-50-4 | C3H4N2S | 详情 | 详情 |
(XV) | 64136 | 2-amino-1,3-thiazole-5-sulfenyl cyanide | 23056-10-2 | C4H3N3S2 | 详情 | 详情 |